| Dr Fred Yong-tao Wu, MD, PHD | |
|
2620 Cota Drive, Bloomington, IN 47403-4211 | |
| (812) 353-2800 | |
| (812) 335-9569 |
| Full Name | Dr Fred Yong-tao Wu |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 17 Years |
| Location | 2620 Cota Drive, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851574073 | NPI | - | NPPES |
| 201070630 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 01070598A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Indiana University Health Bloomington Hospital | Bloomington, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Southern Indiana Physicians Llc | 6204748197 | 449 |
News Archive
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Now, a researcher at the University of Missouri has found that four antiviral drugs, including remdesivir, a drug originally developed to treat Ebola, are effective in inhibiting the replication of the coronavirus causing COVID-19.
OncoSec Medical Inc., a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will re-launch its Phase II cutaneous T-cell lymphoma (CTCL) trial under a protocol amendment.
The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, will be showing its Magstim Rapid2 Therapy System at the Royal College of Psychiatry International Congress 2015 in Birmingham, UK, 29th June-2nd July.
› Verified 9 days ago
| Entity Name | Indiana University Health Southern Indiana Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013953983 PECOS PAC ID: 6204748197 Enrollment ID: O20040423000556 |
News Archive
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Now, a researcher at the University of Missouri has found that four antiviral drugs, including remdesivir, a drug originally developed to treat Ebola, are effective in inhibiting the replication of the coronavirus causing COVID-19.
OncoSec Medical Inc., a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will re-launch its Phase II cutaneous T-cell lymphoma (CTCL) trial under a protocol amendment.
The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, will be showing its Magstim Rapid2 Therapy System at the Royal College of Psychiatry International Congress 2015 in Birmingham, UK, 29th June-2nd July.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fred Yong-tao Wu, MD, PHD Po Box 1329, Bloomington, IN 47402-1329 Ph: (812) 353-2800 | Dr Fred Yong-tao Wu, MD, PHD 2620 Cota Drive, Bloomington, IN 47403-4211 Ph: (812) 353-2800 |
News Archive
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of two types of rare adrenal tumors - pheochromocytomas and paragangliomas - that can raise the risk of cardiovascular disease and even death if left untreated.
Now, a researcher at the University of Missouri has found that four antiviral drugs, including remdesivir, a drug originally developed to treat Ebola, are effective in inhibiting the replication of the coronavirus causing COVID-19.
OncoSec Medical Inc., a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will re-launch its Phase II cutaneous T-cell lymphoma (CTCL) trial under a protocol amendment.
The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, will be showing its Magstim Rapid2 Therapy System at the Royal College of Psychiatry International Congress 2015 in Birmingham, UK, 29th June-2nd July.
› Verified 9 days ago
Dr. Jonathan Andrew Staser, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 429 S Landmark Avenue, Bloomington, IN 47403 Phone: 812-332-8242 Fax: 812-333-7684 | |
Dr. Douglas Geiger, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 429 S Landmark Ave, Bloomington, IN 47403 Phone: 812-332-8242 Fax: 812-333-7684 | |
Dr. Bharati Kharkar, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2620 Cota Dr, Bloomington, IN 47403 Phone: 812-332-8242 Fax: 812-333-7684 | |
Donald C Buehner, Radiology Medicare: Not Enrolled in Medicare Practice Location: 500 S. Landmark Ave, Bloomington, IN 47402 Phone: 812-332-8242 Fax: 812-333-7684 | |
Dr. Philip Doering, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 429 S Landmark Ave, Bloomington, IN 47403 Phone: 812-332-8242 Fax: 812-333-7684 | |
Dr. David Yoon Lee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2620 Cota Dr, Bloomington, IN 47403 Phone: 812-353-2800 Fax: 812-335-9569 | |
Nicholas P Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 429 S Landmark Ave, Bloomington, IN 47403 Phone: 812-332-8242 Fax: 812-333-7684 |